We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks.com featured highlights include Argenx SE Alphatec and Olin
Read MoreHide Full Article
For Immediate Release
Chicago, IL – October 7, 2024 – Stocks in this week’s article are Argenx SE (ARGX - Free Report) , Alphatec Holdings, Inc. (ATEC - Free Report) and Olin Corp. (OLN - Free Report) .
3 Best Earnings Acceleration Stocks to Buy for a Strong Q4
After grappling with recession fears, the Federal Reserve’s jumbo interest rate cuts helped the broader S&P 500 to defy the odds of a notorious September and notch record highs. The S&P 500 posted its best three-quarters of the 21st century, and if history is any guide, the index is well-poised to continue its winning streak over the next three months.
The 30-stock Dow and the tech-laden Nasdaq also closed in the green in the first nine months of 2024. Thus, it’s judicious for astute investors to place their bets on stocks such as Argenx SE, Alphatec Holdings, Inc. and Olin Corp. that can take advantage of the broader market uptrend. This is because these stocks exhibit strong earnings acceleration, often signaling an increase in the stock price.
What is Earnings Acceleration?
Earnings acceleration is the incremental growth in a company’s earnings per share (EPS). In other words, if a company’s quarter-over-quarter earnings growth rate increases within a stipulated time frame, it can be called earnings acceleration.
In the case of earnings growth, you pay for something that is already reflected in the stock price. However, earnings acceleration helps spot stocks that haven’t yet caught the attention of investors and, once secured, will invariably lead to a rally in the share price. This is because earnings acceleration considers both the direction and magnitude of growth rates.
An increasing percentage of earnings growth means that the company is fundamentally sound and has been on the right track for a considerable period. Meanwhile, a sideways percentage of earnings growth indicates a period of consolidation or slowdown, while a decelerating percentage of earnings growth may drag prices down.
The above criteria narrowed the universe of around 7,735 stocks to only three. Here are the stocks:
Argenx
Argenx is a biopharmaceutical company specializing in antibody therapies for autoimmune diseases and cancer treatments. Argenx currently has a Zacks Rank #1 (Strong Buy). ARGX’s expected earnings growth rate for the current year is 92.8%. You can see the complete list of today’s Zacks #1 Rank stocks here.
Alphatec Holdings
Alphatec Holdings is dedicated to creating, and marketing spine disorder surgical treatment products. Alphatec Holdings currently has a Zacks Rank #2 (Buy). ATEC’s expected earnings growth rate for the current year is 29.9%.
Olin Corporation
Olin Corporation is a global producer and distributor of chemical products and a U.S. ammunition maker, with operations in Latin America, Asia Pacific and Europe. Olin Corporation currently has a Zacks Rank #2. OLN’s expected earnings growth rate for the next five years is 28.6%.
You can sign up now for your 2-week free trial to the Research Wizard and start using this screen in your trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks.com featured highlights include Argenx SE Alphatec and Olin
For Immediate Release
Chicago, IL – October 7, 2024 – Stocks in this week’s article are Argenx SE (ARGX - Free Report) , Alphatec Holdings, Inc. (ATEC - Free Report) and Olin Corp. (OLN - Free Report) .
3 Best Earnings Acceleration Stocks to Buy for a Strong Q4
After grappling with recession fears, the Federal Reserve’s jumbo interest rate cuts helped the broader S&P 500 to defy the odds of a notorious September and notch record highs. The S&P 500 posted its best three-quarters of the 21st century, and if history is any guide, the index is well-poised to continue its winning streak over the next three months.
The 30-stock Dow and the tech-laden Nasdaq also closed in the green in the first nine months of 2024. Thus, it’s judicious for astute investors to place their bets on stocks such as Argenx SE, Alphatec Holdings, Inc. and Olin Corp. that can take advantage of the broader market uptrend. This is because these stocks exhibit strong earnings acceleration, often signaling an increase in the stock price.
What is Earnings Acceleration?
Earnings acceleration is the incremental growth in a company’s earnings per share (EPS). In other words, if a company’s quarter-over-quarter earnings growth rate increases within a stipulated time frame, it can be called earnings acceleration.
In the case of earnings growth, you pay for something that is already reflected in the stock price. However, earnings acceleration helps spot stocks that haven’t yet caught the attention of investors and, once secured, will invariably lead to a rally in the share price. This is because earnings acceleration considers both the direction and magnitude of growth rates.
An increasing percentage of earnings growth means that the company is fundamentally sound and has been on the right track for a considerable period. Meanwhile, a sideways percentage of earnings growth indicates a period of consolidation or slowdown, while a decelerating percentage of earnings growth may drag prices down.
The above criteria narrowed the universe of around 7,735 stocks to only three. Here are the stocks:
Argenx
Argenx is a biopharmaceutical company specializing in antibody therapies for autoimmune diseases and cancer treatments. Argenx currently has a Zacks Rank #1 (Strong Buy). ARGX’s expected earnings growth rate for the current year is 92.8%. You can see the complete list of today’s Zacks #1 Rank stocks here.
Alphatec Holdings
Alphatec Holdings is dedicated to creating, and marketing spine disorder surgical treatment products. Alphatec Holdings currently has a Zacks Rank #2 (Buy). ATEC’s expected earnings growth rate for the current year is 29.9%.
Olin Corporation
Olin Corporation is a global producer and distributor of chemical products and a U.S. ammunition maker, with operations in Latin America, Asia Pacific and Europe. Olin Corporation currently has a Zacks Rank #2. OLN’s expected earnings growth rate for the next five years is 28.6%.
You can sign up now for your 2-week free trial to the Research Wizard and start using this screen in your trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today.
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2346328/3-best-earnings-acceleration-stocks-to-buy-in-a-strong-q4
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.